{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:39:28Z","timestamp":1791905968221,"version":"4.3.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Human mpox disease (formerly monkeypox) was first diagnosed in an infant in the Democratic Republic of the Congo in 1970. Mpox was rarely reported outside West and Central Africa until the global outbreak in May 2022. On 23 July 2022, the WHO declared mpox a public health emergency of international concern. These developments warrant a global update on pediatric mpox.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Mpox epidemiology in endemic African countries has changed from predominantly affecting children under 10 years to adults 20\u201340 years old. This shift also applies to the global outbreak, where 18\u201344-year-old adult men who have sex with men are disproportionately affected. Furthermore, the proportion of children affected in the global outbreak is less than 2%, while children under 18\u200ayears constitute nearly 40% of cases in African countries. The highest mortality rates remain among both children and adults in African countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Mpox epidemiology has shifted to adults and is affecting relatively few children in the current global outbreak. However, infants, immunocompromised children and African children are still at high risk of severe disease. Mpox vaccines and therapeutic interventions should be accessible to at-risk and affected children globally, especially to those living in endemic African countries.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001232","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T09:18:25Z","timestamp":1676971105000},"page":"193-200","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["A global update of mpox (monkeypox) in children"],"prefix":"10.1097","volume":"35","author":[{"given":"Nadia A.","family":"Sam-Agudu","sequence":"first","affiliation":[{"name":"International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria"},{"name":"Division of Epidemiology and Prevention, Institute of Human Virology"},{"name":"Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA"},{"name":"Department of Paediatrics and Child Health, University of Cape Coast School of Medical Sciences, Cape Coast"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Martyn-Dickens","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atana U.","family":"Ewa","sequence":"additional","affiliation":[{"name":"Respiratory\/Infectious Diseases Unit, Department of Paediatrics, University of Calabar and University of Calabar Teaching Hospital, Calabar, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"R4-20250730","first-page":"369","article-title":"Monkeypox in Africa: future health hazard or public health nuisance?","volume":"1","year":"1987","journal-title":"Lancet"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","article-title":"Emergence of monkeypox as the most important orthopoxvirus infection in humans","volume":"6","author":"Sklenovsk\u00e1","year":"2018","journal-title":"Front Public Health"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox\u2014a potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3201\/eid1306.061540","article-title":"Endemic human monkeypox, Democratic Republic of Congo, 2001\u20132004","volume":"13","author":"Rimoin","year":"2007","journal-title":"Emerg Infect Dis J"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1086\/498115","article-title":"Clinical characteristics of human monkeypox, and risk factors for severe disease","volume":"41","author":"Huhn","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3201\/eid2812.220897","article-title":"National monkeypox surveillance, Central African Republic, 2001\u20132021","volume":"28","author":"Besombes","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"e2022060179","DOI":"10.1542\/peds.2022-060179","article-title":"Mpox in children and adolescents: epidemiology, clinical features, diagnosis, and management","volume":"151","author":"Beeson","year":"2022","journal-title":"Pediatrics"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"102386","DOI":"10.1016\/j.tmaid.2022.102386","article-title":"New challenges in human monkeypox outside Africa: a review and case report from Italy","volume":"49","author":"Mileto","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.15585\/mmwr.mm7145a4","article-title":"Epidemiologic features of the monkeypox outbreak and the public health response \u2013 United States, May 17\u2013October 6, 2022","volume":"71","author":"Kava","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries \u2013 April\u2013June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/v12111257","article-title":"Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution","volume":"12","author":"Alakunle","year":"2020","journal-title":"Viruses"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of human monkeypox in Nigeria in 2017\u201318: a clinical and epidemiological report","volume":"19","author":"Yinka-Ogunleye","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical course and outcome of human monkeypox in Nigeria","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"ofac310","DOI":"10.1093\/ofid\/ofac310","article-title":"Monkeypox: a contemporary review for healthcare professionals","volume":"9","author":"Titanji","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R29-20250730","first-page":"465","article-title":"Human monkeypox: secondary attack rates","volume":"66","author":"Jezek","year":"1988","journal-title":"Bull World Health Organ"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/vaccines10122091","article-title":"Disease history, pathogenesis, diagnostics, and therapeutics for human monkeypox disease: a comprehensive review","volume":"10","author":"Saied","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2210015","article-title":"Tecovirimat for monkeypox in Central African Republic under expanded access","volume":"387","author":"Mbrenga","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:08:20Z","timestamp":1753898900000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001232","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}